Understanding asthma attacks in patients with infrequent medical visits
Official title: Predicting Exacerbations of Asthma in Real-World Patients with Low Medical Utilization (PEARL)
Funded at Kaiser Foundation Research Institute · NIH-11012362 · Data updated 2026-11-12
This study is looking at what causes asthma flare-ups in people who don’t often go to the doctor, so we can find better ways to help them manage their asthma and feel better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project start | February 21, 2023 |
| Project end | December 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $666,755 |
| NIH project number | 5R01HL163049-03 |
| Project ID | NIH-11012362 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with intermittent asthma who have low medical utilization and experience occasional asthma symptoms.
✕Less likely to help
Patients with persistent asthma or those who frequently utilize medical services may not benefit from this research.
What this research studies
This research investigates the risk factors that lead to asthma exacerbations in patients who do not frequently seek medical care. By focusing on individuals with intermittent asthma, the study aims to identify specific triggers and develop predictive models that can help in managing their condition more effectively. Patients will be monitored for symptoms, medication use, and other relevant factors to gather comprehensive data. The goal is to create a personalized approach to asthma management that can improve patient outcomes.
Why it matters
Potential benefit: If successful, this research could lead to better prediction and management of asthma attacks, ultimately improving the quality of life for patients.
How similar studies have gone: Previous research has shown success in identifying risk factors for asthma exacerbations in persistent asthma, but this approach focusing on intermittent asthma is relatively novel.
Where this research is happening
-
Kaiser Foundation Research Institute
Oakland, United States Active
Researchers
- Principal investigator: Chen, Wansu — Kaiser Foundation Research Institute
- Study coordinator: Chen, Wansu
Related research
Other NIH-funded projects on the same topics.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
Expanding understanding of asthma in kids through airways and blood profiling
A study at UC San Francisco will profile blood and nasal/sputum samples from 300 youth (including 200 with asthma) over a year to understand how environmental and social factors influence asthma in marginalized communities.
-
Preventing and improving asthma care for children in urban communities
This program will try several approaches — from giving helpful bacteria to babies to allergy immunotherapy and advanced airway testing — to prevent and better treat asthma in children who live in cities.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.